Aridis Pharmaceuticals
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
983 University Ave Bldg B, Los Gatos, Ca...Phone Number
(408) 385-1742Website
www.aridispharma.comRevenue
$22.4 MillionStock Symbol
ARDSIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Aridis Pharmaceuticals
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. Aridis Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Los Gatos, California.Explore more
Aridis Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aridis Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Aridis Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Aridis Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Aridis Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Aridis Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Aridis Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Aridis Pharmaceuticals
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Aridis Pharmaceuticals has new funding data
Check out if Aridis Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Aridis Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Aridis Pharmaceuticals
Compare insights from companies similar to Aridis Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aridis Pharmaceuticals
$22.4M
11-50
Public
$6.8M
2003
YW
Yvonne WalkerAssociate Director, Clinical Operations
$19.7M
11-50
Private
-
1989
RK
Randie KutzenDeputy Executive Director, Operations & Program Director, Iddap
Company Profile Activity
Activity Insights
Aridis Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aridis Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aridis Pharmaceuticals.
Aridis Pharmaceuticals financials insights
Gather financial insights about Aridis Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$3.5M
2015
Debt
$3M
2020
Debt
$350K
Aridis Pharmaceuticals Tech Stack
A closer look at the technologies used by Aridis Pharmaceuticals
See more technologies
Most Recent Scoops
Project
, according to a high-level source in marketing, is planning to leverage AI-driven data enrichment and hygiene over the next six to twelve months.
Artificial Intelligence
Executive Move
Board of Directors
Earnings
Aridis Pharmaceuticals has reported revenues of $1.19 million for Q1 2022, missing expectations of $2.00 million.
Earnings
Open Position
Open Position
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aridis Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the tr... Read More
